الوصف
Berberine's effects on lipid metabolism biomarkers in NAFLD models show favorable changes in triglyceride, total cholesterol, and LDL levels. The magnitude of improvement appears to correlate with treatment duration and dosage.
Figure 9
ChartSource Paper
Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Clinical and Pre-Clinical Overview and Systematic Review of the Literature.Cite This Figure
![Figure 9: Berberine's effects on lipid metabolism biomarkers in NAFLD models show favorable changes in triglyceride, total cholesterol, and LDL levels. The magnitude of improvement appears to correlate with treatment duration and dosage.]() > Source: Florentina Ionita-Radu et al. "Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Cl." *International journal of molecular sciences*, 2024. PMID: [38673787](https://pubmed.ncbi.nlm.nih.gov/38673787/)
<figure> <img src="" alt="Berberine's effects on lipid metabolism biomarkers in NAFLD models show favorable changes in triglyceride, total cholesterol, and LDL levels. The magnitude of improvement appears to correlate with treatment duration and dosage." /> <figcaption>Figure 9. Berberine's effects on lipid metabolism biomarkers in NAFLD models show favorable changes in triglyceride, total cholesterol, and LDL levels. The magnitude of improvement appears to correlate with treatment duration and dosage.<br> Source: Florentina Ionita-Radu et al. "Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Cl." <em>International journal of molecular sciences</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38673787/">38673787</a></figcaption> </figure>